Adrianna Lebiedzińska | Low-Triiodothyronine Syndrome | Research Excellence Award

Published on by TOT Awards

Dr. Adrianna Lebiedzińska | Low-Triiodothyronine Syndrome | Research Excellence Award

University Clinical Hospital in Wroclaw | Poland

Dr. Adrianna Łebiedzińska, MD, is a resident in anesthesiology and intensive care at the University Clinical Hospital in Wrocław, Poland, specializing in neurocritical care. Her research focuses on metabolic and endocrine disturbances following acute brain injury, particularly aneurysmal subarachnoid hemorrhage. She has contributed to advancing prognostic assessment through her work on low triiodothyronine (T3) syndrome, including the development of a novel reference-adjusted FT3 metric that improved predictive model performance. Dr. Łebiedzińska has published in Biomedicines (2026) and actively collaborates with multidisciplinary clinical research teams at Wrocław Medical University. A member of the Polish Society of Anaesthesiology and Intensive Therapy, her work aims to enhance clinical decision-making and patient outcomes in critically ill neurological populations, reflecting a strong commitment to translational research and healthcare impact.

ORCID

Featured Publications

A Lebiedzińska, M Burzyńska, J Woźniak, W Goździk (2026).
The Prognostic Significance of Low-Triiodothyronine Syndrome in Aneurysmal Subarachnoid Hemorrhage
Biomedicines | Journal Article · 2026 · DOI: 10.3390/biomedicines14030603

M Burzyńska, J Woźniak, A Uryga, A Lebiedzińska, M Kasprowicz, W Goździk (2022).
Wpływ wczesnego uszkodzenia mózgu na rozwój wtórnego niedokrwienia i wczesny wynik leczenia chorych po krwotoku podpajęczynówkowym z pękniętego tętniaka
Forum Zakażeń | Conference Paper · 2022

A Lebiedzińska, A Uryga, M Burzyńska (2022).
Zaburzenia ogólnoustrojowe w ostrej fazie u chorych z patologią wewnątrzczaszkową – opis przypadku
Wrocławska Wiosna Anestezjologiczna | Conference Paper · 2022

A Lebiedzińska, A Uryga, M Burzyńska (2022).
Zaburzenia ogólnoustrojowe w ostrej fazie u chorych z patologią wewnątrzczaszkową – opis przypadku
Wrocławska Wiosna Anestezjologiczna | Conference Poster · 2022

Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Published on by TOT Awards

Dr. Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Hamamatsu University School of Medicine | Bangladesh

Dr. Mohammad Khaja Mafij Uddin is an Associate Scientist in the Infectious Diseases Division at icddr,b, with over 15 years of expertise in mycobacteriology and tuberculosis (TB) diagnostics. His work integrates molecular, microbiological, and immunological approaches to advance TB detection, drug resistance analysis, and biomarker discovery. He has led and contributed to multiple internationally funded projects, including collaborations with organizations in France, Korea, and the USA, focusing on innovative diagnostics such as targeted next-generation sequencing and non-respiratory TB detection. Dr. Uddin has authored several peer-reviewed publications in high-impact journals, contributing significantly to understanding TB transmission dynamics and extrapulmonary TB. He has mentored graduate students and strengthened laboratory capacity, with his research directly supporting improved TB diagnosis and public health outcomes in high-burden settings.

Citation Metrics (Scopus)

94
75
50
25
0

Citations
94

h-index
4

Documents
5

Citations

h-index

Documents

Featured Publications

Liu Wenyi | Health Sciences | Best Researcher Award

Published on by TOT Awards

Dr. Liu Wenyi | Health Sciences | Best Researcher Award

Cancer Hospital Chinese Academy of Medical Sciences | China

Dr. Liu Wenyi is a thoracic-surgery specialist whose research focuses on advanced treatments for thoracic malignancies especially esophageal and lung cancers emphasising organ-preservation strategies, neoadjuvant chemo-/chemo-immunotherapy, imaging- and machine-learning-based response assessment, and translational biomarkers for surgical decision-making. His work has contributed to the evolving paradigm of less-invasive surgery and more personalised multimodal care. For example, his recent narrative review “Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions” is a state-of-the-field synthesis published in Cancers  highlighting novel surveillance-based approaches in esophageal squamous cell carcinoma. His Google Scholar/Scopus profile indicates approximately 10 publications and a current h-index of 5 (citations ~80) under his name. This volume reflects a mid-career emerging investigator whose trajectory is marked by high-impact topics (thoracic oncology, immunotherapy, AI-enabled imaging) and whose top publications already appear in high-visibility journals. Dr. Liu’s work is characterized by integrating minimally invasive surgical techniques, cutting-edge neoadjuvant systemic treatments and advanced predictive modelling to stratify patients for surgical risk and organ-sparing pathways thus contributing to both improved patient quality of life and optimized oncologic outcomes.His outstanding contributions to clinical innovation and scientific research excellence reflect strong merit for recognition under the Best Researcher Award .

Publication Profile

Orcid

Featured Publications

Liu, W., Guo, X., Zhao, H., Yu, X., Wang, C., Du, L., Wang, F., & Mu, J. (2020). Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: A single-center initial experience. Journal of Thoracic Disease, 12(9), 4908-4914.

Liu, W., Tang, J., Li, X., Gong, L., Yang, D., Yin, H., Wang, W., & Zhang, B. (2025). Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer. Oncology Letters, 30(5), 501.

Liu, W., Sui, Z., Wang, C., Deng, Y., Cai, S., Jia, R., Yu, Z., Kang, M., & Zhang, B. (2025). Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 13, 1679782.

Hong, Z., Xie, S., Xu, H., Ke, S., Liu, W., Huang, S., Chen, S., Xie, J., Xu, J., & Kang, M. (2025). Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study. European Journal of Surgical Oncology, 51(2), 109500.

Liu, W., Zhang, B., Wang, C., Yu, X., Du, L., Yu, Z., & Kang, M. (2025). Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions. Cancers, 17(21), 3559.

 

EMMANUEL SCALAIS | Medicine and Health Sciences | Outstanding Scientist Award

Published on by TOT Awards

Dr.EMMANUELSCALAIS|MedicineandHealth Sciences| Outstanding Scientist Award

MD at NEPE, Luxembourg.

Dr. Emmanuel Scalais is the Chief Physician of the Pediatric Neurology Department at Centre Hospitalier de Luxembourg (CHL)He has authored 82 publications and has been cited 2,877 times in the field of pediatric neurology.His clinical expertise includes conditions such as homocystinuria, vitamin B12 deficiency anemia, and exocrine pancreatic insufficiency.

professional profiles📖

Education 🎓

Secondary School: Humanity Greco-Latine (June 1972), Collège du Sacré-Coeur, Charleroi, BelgiumHigh School: Université Catholique de LouvainBaccalauréat en Philosophie: Magna cum Laude (June 1975)Doctor of Medicine: Laude (June 1979)

work Experience💼

1988-2002: Pediatric Neurologist, CHC Espérance & Saint Vincent, Liège, Belgium (Full-time)Lecturer: Pediatric Neurology Course for nurses at “School of Sainte-Julienne,” LiègeLecturer: “Medical Approach of Handicap” in Orthopédagogie2003-2024: Pediatric Neurologist, Centre Hospitalier de Luxembourg, Department of Pediatrics (Full-time)Head of Pediatric Neurology Division (2014-2018, 2018-2024)Lecturer: Pediatric Neurology Course for nurses at “Lycée Technique pour Professions de Santé” (2006-2024)

Research Focus

Dr. Scalais has authored numerous peer-reviewed articles, with a focus on pediatric neurology, metabolic disorders, and neonatal brain function. Notable contributions include:Research on phenobarbital’s effects on cerebral blood flow in newbornsStudies on very long-chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant deathInvestigations into early myoclonic epilepsy linked to CoQ10 deficiencyDiagnostic and prognostic value of evoked potentials in neonatal hypoxiaCase studies on mitochondrial disorders, such as Leigh’s encephalopathy and POLG mutationsHydroxocobalamin dose intensification in early-onset cobalamin metabolism defects

Conclusion

Dr. Scalais based on his , , and . While increasing could further strengthen his profile, his current body of work already demonstrates and .is highly suitable for this awardsignificant contributions to pediatric neurology researchclinical impactinternational collaborationshigh-impact publications, principal investigator roles, and research fundingoutstanding scientific meritlong-term dedication to pediatric neurology

📚Publications to Noted

  • Scalais E, Beharry K, Papageorgiou A, Bureau M, Aranda JV (1992). Effects of phenobarbital on cerebral blood flow in the newborn piglet. Developmental Pharmacology and Therapeutics, 19(1), 10-18. [doi: 10.1159/000457457]

  • Scalais E, Bottu J, Wanders RJ, Ferdinandusse S, Waterham HR, De Meirleir L (2015). Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis. American Journal of Medical Genetics Part A, 167A(1), 211-214. [doi: 10.1002/ajmg.a.36803]

  • Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, Smet J, De Meirleir L (2013). Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). European Journal of Paediatric Neurology, 17(6), 625-630. [doi: 10.1016/j.ejpn.2013.05.013]

  • Scalais E, Connerotte AC, Despontin K, Biver A, Ceuterick-de Groote C, Alders M, Kolivras A, Hachem JP, De Meirleir L (2016). Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype. American Journal of Medical Genetics Part A, 170(7), 1799-1805. [doi: 10.1002/ajmg.a.37673]

  • Scalais E, Francois A, Nuttin C (1996). [Diagnostic and prognostic value of evoked potentials facing cerebral hypoxia in newborn infants]. Archives de Pédiatrie, 3 Suppl 1, 251s-253s. [doi: 10.1016/0929-693x(96)86058-1]

  • Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Lofgren A, De Meirleir L (2012). Polymerase gamma deficiency (POLG): clinical course in a child with a two-stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy. European Journal of Paediatric Neurology, 16(5), 542-548. [doi: 10.1016/j.ejpn.2012.01.013]

  • Scalais E, Francois-Adant A, Nuttin C, Bachy A, Guerit JM (1998). Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns. Electroencephalography and Clinical Neurophysiology, 108(2), 199-207. [doi: 10.1016/s0168-5597(97)00076-2]

  • Scalais E, Geron C, Pierron C, Cardillo S, Schlesser V, Mataigne F, Borde P, Regal L (2023). Would early versus late hydroxocobalamin dose intensification treatment prevent cognitive decline, macular degeneration and ocular disease in 5 patients with early-onset cblC deficiency? Molecular Genetics and Metabolism, 140(3), 107681. [doi: 10.1016/j.ymgme.2023.107681]

  • Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B, Martin JJ, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R (2007). Infantile presentation of the mitochondrial A8344G mutation. European Journal of Neurology, 14(11), e3-5. [doi: 10.1111/j.1468-1331.2007.01926.x]

  • Scalais E, Osterheld E, Geron C, Pierron C, Chafai R, Schlesser V, Borde P, Regal L, Laeremans H, van Gassen KLI, van den Heuvel LPWJ, De Meirleir L (Under revision). Parenteral Hydroxocobalamin Dose Intensification in 5 Patients with Different Types of Early Onset Intracellular Cobalamin Defects: Clinical and Biochemical Responses. Journal of Inherited Metabolic Disease.

Hanseob Shin | Antimicrobial | Best Researcher Award

Published on by TOT Awards

Dr. HanseobShin | Antimicrobial | Best Researcher Award

Postdoc scholar at University of iowa,United States

Dr. Hanseob Shin is a dedicated environmental microbiologist specializing in tracking environmental contamination, microbial ecology, and antimicrobial resistance in water systems. As a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, he actively investigates the fate and transport of antibiotic-resistant bacteria in various aquatic environments. His research applies CRISPR spacerome analysis and microbial source tracking to understand the dynamics of contamination sources. With extensive experience in environmental microbiology, Dr. Shin has contributed significantly to identifying antibiotic-resistant genes in wastewater and river systems, improving public health risk assessment. He has authored numerous scientific publications in prestigious journals and actively participates in national and international conferences. Through his research, he aims to develop innovative solutions for mitigating microbial contamination in natural and engineered water systems, promoting environmental sustainability and health protection.

Professional Profile

Scopus Profile

ORCID

Education 🎓

Dr. Hanseob Shin obtained his Ph.D. in Earth Sciences and Environmental Engineering from the Gwangju Institute of Science and Technology, South Korea, in 2022. His doctoral research focused on long-term monitoring of antibiotic resistance genes and bacteria in rivers and wastewater treatment plants, providing valuable insights into microbial contamination dynamics. Before his Ph.D., he earned a Bachelor of Science in Molecular Biotechnology from Chonnam National University in 2015, where he developed a strong foundation in microbial genetics and biotechnology. His academic journey has been marked by a keen interest in microbial ecology, antibiotic resistance, and environmental health. Dr. Shin’s education has equipped him with expertise in advanced microbiological techniques, including metagenomics, CRISPR engineering, and microbial source tracking. His interdisciplinary training bridges environmental science and molecular biotechnology, enabling him to address pressing challenges in water quality management and public health protection.

Work Experience 💼

Dr. Hanseob Shin has accumulated extensive experience in environmental microbiology and microbial source tracking. Since 2022, he has been a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, where he investigates antimicrobial resistance in water systems. Prior to this, he worked as a Postdoctoral Research Associate at the Gwangju Institute of Science and Technology, contributing to research on microbial contamination in wastewater treatment plants. His work has involved the application of molecular and genomic tools to study antibiotic-resistant bacteria in environmental settings. Additionally, he has collaborated with government agencies and research institutions to assess microbial contamination in agricultural and urban water sources. Through his academic and research roles, Dr. Shin has developed a strong expertise in microbial ecology, CRISPR-based bacterial identification, and the environmental impact of antibiotic resistance genes.

Research Interests 🔬

Dr. Hanseob Shin’s research is centered on environmental microbiology, microbial ecology, and the fate and transport of antimicrobial resistance in water systems. He investigates the spread of antibiotic-resistant bacteria in aquatic environments, including wastewater treatment plants, rivers, and agricultural runoff. His work utilizes CRISPR spacerome analysis for strain-level bacterial identification and microbial source tracking to trace contamination origins. Dr. Shin also explores the role of core antibiotic resistance genes as indicators of pollution in wastewater and natural water bodies. His studies contribute to improving strategies for mitigating microbial risks in water systems. Additionally, he examines the genetic diversity of antibiotic-resistant bacteria, aiming to understand their persistence and potential health risks. His research has practical applications in public health, environmental policy, and water treatment technologies, promoting safer water resources and sustainable environmental management.

Awards & Achievements 🏆

Dr. Hanseob Shin has received recognition for his outstanding research contributions in environmental microbiology. In 2022, he was awarded the Outstanding Best Poster Award at the International Symposium and Annual Meeting of the KSABC for his work on antibiotic resistance genes in effluent and receiving water. His research projects have secured significant funding, including a $300,000 grant from the Chicago Community Trust for studying antibiotic-resistant bacteria in Iowa’s concentrated animal feeding operations (CAFOs). He has also received substantial research grants from the Rural Development Administration and the Korea Environmental Industry & Technology Institute for projects related to wastewater treatment and antibiotic-resistant organisms. His contributions as a peer reviewer for high-impact journals further highlight his expertise in the field. Dr. Shin’s accolades reflect his dedication to advancing scientific knowledge on microbial contamination and public health.

Conclusion

Dr. Hanseob Shin is a strong candidate for the Best Researcher Award due to his impactful contributions to environmental microbiology, antibiotic resistance, and microbial tracking. His extensive publication record, research funding, and conference presentations position him as an emerging leader in his field. While he could enhance his profile by expanding his independent research leadership and mentorship roles, his current achievements make him a highly competitive nominee for this prestigious award.

Top Noted Publications 📚

Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance

Authors: Not specified

Year: 2022

Citations: Not specified

Prevalence and Characterization of CRISPR Locus 2.1 Spacers in Escherichia coli Isolates Obtained from Feces of Animals and Humans

Authors: Not specified

Year: 2023

Citations: Not specified

Resistome Study in Aquatic Environments

Authors: Not specified

Year: 2023

Citations: Not specified

Dynamics of Genotypic and Phenotypic Antibiotic Resistance in a Conventional Wastewater Treatment Plant in 2 Years

Authors: Not specified

Year: 2022

Citations: Not specified

Geographical distribution and genetic diversity of Bradyrhizobium spp. isolated from Korean soybean root nodules

Authors: Not specified

Year: 2022

Citations: Not specified

Higher abundance of core antimicrobial resistant genes in effluent from wastewater treatment plants

Authors: Not specified

Year: 2022

Citations: Not specified

Phylogenetic diversity and spatiotemporal dynamics of bacterial and microeukaryotic plankton communities in Gwangyang Bay of the Korean Peninsula

Authors: Not specified

Year: 2022

Citations: Not specified

Emergence of High Level Carbapenem and Extensively Drug Resistant Escherichia coli ST746 Producing NDM-5 in Influent of Wastewater Treatment Plant, Seoul, South Korea

Authors: Not specified

Year: 2021

Citations: Not specified

Metagenomic exploration of antibiotic resistome in treated wastewater effluents and their receiving water

Authors: Not specified

Year: 2021

Citations: Not specified

High genetic diversity of Vibrio parahaemolyticus isolated from tidal water and mud of southern coast of South Korea

Authors: Not specified

Year: 2019

Citations: Not specified

Metagenomic analysis reveals the prevalence and persistence of antibiotic- and heavy metal-resistance genes in wastewater treatment plant

Authors: Not specified

Year: 2018

Citations: Not specified